Interest of Maintenance Chemotherapy After Induction Treatment for Inflammatory Breast Cancer

Inclusion Criteria: * histologically proven breast cancer * inflammatory breast cancer * no metastatic site * age \> or = 18 and \< or = 60 * OMS score: 0, 1, 2 * life expectancy \> or = 3 months * Normal (isotopic or ultrasonography) left ventricular ejection fraction * Normal haematological, liver, and kidney functions * patients who gave their written informed consent. Exclusion Criteria: * non inflammatory breast tumour with a cutaneous permeation nodule * presence of a metastatic site * medical history of a cancerous tumour except for carcinoma in situ of the uterine cervix, a basal cell skin cancer, or a breast carcinoma on the contralateral side * patients having already had a chemotherapy, a radiotherapy, or an hormone therapy for this breast tumour * medical history of congestive heart failure even medically controlled * medical history of myocardial infarction during the 6 months before the inclusion in the study * active infection or other severe underlying pathology which could possibly prevent the patient from receiving treatments * administration of another chemotherapy during the study * pregnant or breast feeding patients (the patients of childbearing age must be placed under efficient contraception) * patients whose social or psychological state does not allow to consider a correct adherence to the treatment and to the required medical follow-up * WHO score 3,4 * unbalanced diabetes * polysorbate 80 allergy